LONDON: In a news release, Schroders Capital Global Innovation Trust plc (INOV) has announced its final results for the fiscal year ending December 31, 2023. The company, under the leadership of Chair Tim Edwards, has reported a notable increase in…
LONDON, UK: Schroders Capital Global Innovation Trust has made an investment of $1.6 million (£1.3 million) in Neurona Therapeutics, a US-based clinical-stage cell therapy company. The Company participated in Neurona’s Series E financing round, which raised $120 million and was…
LONDON: Schroders Capital Global Innovation Trust has made a commitment of CHF 0.9 million (£0.8 million) to Memo Therapeutics AG, a Switzerland-based clinical-stage biopharmaceutical company. The Company participated in Memo’s Series C financing round, which raised CHF 25 million and…